Jaguar Health (JAGX) Notes Payables (2014 - 2026)

Jaguar Health (JAGX) has 13 years of Notes Payables data on file, last reported at $22.1 million in Q1 2026.

• Notes Payables for Q1 2026 came in at $22.1 million, up 18.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.1 million (up 18.46% YoY), and the FY2025 annual result was $27.4 million, up 127.94% from the prior year.
• Notes Payables retreated to $22.1 million in Q1 2026 per JAGX's latest filing, from $27.4 million in the prior quarter.
• Over five years, Notes Payables peaked at $27.4 million in Q4 2025 and troughed at $3.5 million in Q3 2023.
• A 5-year average of $13.8 million and a median of $12.0 million in 2024 frame the typical range for Notes Payables.
• The sharpest annual moves came in 2022 and 2023: Notes Payables jumped 594.59% in 2022, then plunged 70.1% in 2023.
• A 5-year view of Notes Payables shows it stood at $15.9 million in 2022, then tumbled by 69.36% to $4.9 million in 2023, then jumped by 147.34% to $12.0 million in 2024, then jumped by 127.94% to $27.4 million in 2025, then retreated by 19.54% to $22.1 million in 2026.
• Business Quant data shows JAGX's Notes Payables at $22.1 million in Q1 2026, $27.4 million in Q4 2025, and $23.1 million in Q3 2025.